ALS Untangled Series Ep. 60 - Nuedexta

CReATe Podcast
04/12/2024 24 min
ALS Untangled Series Ep. 60 - Nuedexta

Listen "ALS Untangled Series Ep. 60 - Nuedexta"

Descargar episodio Ver en sitio original

Episode Synopsis

Nuedexta is a combination of dextromethorphan and quinidine, and is FDA approved for treating “pseudobulbar affect” (a symptom complex where patients lose control of their laughing and crying).  Here we summarize recent trials suggesting that Nuedexta might also help bulbar function (speech, swallowing and oral secretions).  We also discuss important risks, monitoring, and insurance coverage.

More episodes of the podcast CReATe Podcast

ALS Untangled Series Ep. 62 - Ashwagandha 20/10/2025
CReATe Author Series Ep. 16 - Dr. Johnathan Cooper-Knock on Exercise and ALS 24/09/2025
ALS Untangled Series Ep. 61 - Zinc 09/09/2025
CReATe Author Series Ep. 15 - Drs. Terry Heiman-Patterson and Michael Benatar on Clinical Guidance for ALS/FTD at-risk carriers 02/06/2025
CReATe Author Series Ep. 14 - Drs. Ruben van Eijk and Michael Benatar on Phase 2 Trials and ALS 01/05/2025
CReATe Author Series Ep. 13 - Dr. Benatar on Prognostic Markers and ALS 18/02/2025
CReATe Author Series Ep. 12 - Drs. Jesse Crayle and Evadnie Rampersaud on Genetics and ALS Reversal Phenotype 02/01/2025
ALS Untangled Series Ep. 59 - Lions Mane 04/11/2024
ALS Untangled Series Ep. 58 - Insulin 01/10/2024
ALS Untangled Series Ep. 57 - Caffeine 05/09/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA